Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

HY21 report: What to do with Appen (ASX:APX) shares?

Since releasing its HY21 result last week, Appen's (ASX:APX) shares are down over 25%. Where to from here?

Shares in artificial intelligence company Appen Limited (ASX: APX) fell another 6% on Friday. This means that since releasing its HY21 result lastWednesday, Appen’s shares are down over 25%.

For a full breakdown of Appen’s recent results, click here to read my colleague, Jaz Harrison’s article: HY21 result: Appen (ASX: APX) share price sinks.

Source: Rask Media APX 2-year share price chart

Growth slows

When I last wrote about Appen before it reported, I mentioned that I’d be watching the performance of its global division that could indicate the start of a turnaround.

It was anticipated that Appen’s first half of the year is usually slower than the second due to timing around project delivery. This saw global revenue come in at $148.5 million, a 9% decrease on 1H20.

Group underlying EBITDA was $27.7 million, down 14.3%, and considerably under consensus forecasts. This was partly due to the increased investment in its New Markets segment.

Management flagged a decrease in full-year EBITDA guidance and is now expecting somewhere between $81 million and $88 million for the full year.

Underlying net profit after tax (NPAT) fell 35% to $12.5 million, which was largely affected by increased amortisation from product development.

What does the future hold for Appen?

Management have been saying for quite some time that some of their large customers have been reprioritising their projects and resources in light of COVID.

If you take the view that these complications are in fact transitory, it could be business as usual for Appen moving forward.

Unfortunately, I don’t think the market is buying the recovery story as much anymore. It’s true that AI is still a growing industry, but it doesn’t seem to be reflected in Appen’s recent performance which seems odd considering how other tech companies have stood to benefit from the pandemic.

Instead, there’s been more evidence to suggest that companies have been internalising AI training data and using AI itself to label data rather than a human-trained workforce.

If this is true moving forward, I think it’s reasonable to assume AI training costs will fall as there will be more competition and data labeling will become a less niche industry.

Summary

Some might be starting to see some value in Appen’s shares considering the huge drawdown.

One of the main risks here is that the turnaround might not happen as one would expect. If this is the case, buying into a company with a decreasing intrinsic value can be a quick way to erode your capital where time is unfortunately working against you.

If I was considering becoming an Appen shareholder, I’d be wanting to see more demonstrated evidence of a turnaround.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content